Exane Derivatives Kura Oncology, Inc. Transaction History

Exane Derivatives

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$20.85 - $29.88 $96,035 - $137,627	-4,606 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$24.75 - $39.14 $22,101 - $34,952	-893 Reduced 16.24%	4,606 $130,000
Q4 2020 Jan 27, 2021	SELL	$29.0 - $41.62 $60,465 - $86,777	-2,085 Reduced 27.49%	5,499 $179,000
Q3 2020 Oct 06, 2020	BUY	$16.3 - $30.64 $4,482 - $8,426	275 Added 3.76%	7,584 $232,000
Q2 2020 Jul 10, 2020	SELL	$7.95 - $18.81 $19,048 - $45,068	-2,396 Reduced 24.69%	7,309 $119,000
Q1 2020 Apr 17, 2020	BUY	$6.45 - $14.04 $62,597 - $136,258	9,705 New	9,705 $96,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.